Life Sciences

Tahmidur Remura Dewey LeBoeuf’s lawyers employ a multidisciplinary approach to meeting our life sciences clients’ needs, leveraging experience in our intellectual property (IP), mergers and acquisitions, litigation, tax and other related practices. In particular, our clients in the life sciences sector benefit from our services as they face challenges specific to the sector, from strategic IP planning in a complex scientific and regulatory environment, to pipeline expansion through licensing, strategic alliances and acquisitions. Lawyers practicing in the life sciences field have technical backgrounds in molecular biology, biochemistry and related disciplines.

Our clients include established pharmaceutical and biotechnology companies, start-up and emerging companies, medical device companies, clinical research organizations, philanthropic institutions, private equity firms, venture capital firms, pension funds and investment banks.

Representative Clients

  • Abbott
  • Gilead
  • Illumina
  • Medicis
  • MedImmune
  • Medtronic
  • Merz Pharma
  • Novartis
  • Onyx Pharmaceuticals
  • Progenics
  • Pronova Biopharma

Representative Transactions

  • Represented Novartis in connection with the development, promotion and manufacture of emerging antiviral compounds and, in a separate transaction, the in-licensing of best-in-class siRNA technology
  • Represented Medimmune in its $15.6 billion acquisition by AstraZeneca
  • Represented King Pharmaceuticals in its successful $1.6 billion hostile offer to acquire Alpharma
  • Represented underwriters in IPOs, convertible securities and follow-in equity offerings by life sciences companies with an aggregate value of over $2 billion

Representative Patent Infringement Experience

  • The prosecution and defense of many patent cases involving medical devices such as spinal implants, laparoscopic surgical instruments and sutures, coronary stents, bioprosthetic heart valves, cardiac pacemakers and defibrillators, optics, hip and breast implants, incontinence products and medical imaging systems
  • The prosecution and defense of patent cases involving biologics such as monoclonal antibody technology, human papillomavirus technology, the diagnostic use of monoclonal antibodies and a tumor necrosis factor-alpha blocker
  • The prosecution and defense of numerous patent infringement cases involving branded pharmaceuticals, vaccines, intermediates and ophthalmic products
Click to view a complete pdf brochure describing our Life Sciences practice and representative matters.

Related Services